Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 629

    1.

    Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Diabetes. 2006 Nov;55(11):3038-46.PMID: 17065340 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1695-706. Epub 2005 Feb 17.PMID: 15718384 [PubMed - indexed for MEDLINE]Related articles

    3.

    Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

    Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR.

    Endocrinology. 2005 Dec;146(12):5120-7. Epub 2005 Sep 8.PMID: 16150917 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Endocrinology. 2005 Feb;146(2):879-88. Epub 2004 Nov 11.PMID: 15539554 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1064-70. Epub 2004 Jul 8.PMID: 15242829 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men.

    Brennan IM, Otto B, Feltrin KL, Meyer JH, Horowitz M, Feinle-Bisset C.

    Peptides. 2007 Mar;28(3):607-11. Epub 2006 Nov 28.PMID: 17129639 [PubMed - indexed for MEDLINE]Related articles

    7.

    GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.

    Näslund E, Bogefors J, Skogar S, Grybäck P, Jacobsson H, Holst JJ, Hellström PM.

    Am J Physiol. 1999 Sep;277(3 Pt 2):R910-6.PMID: 10484511 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.

    Reidelberger RD, Arnelo U, Granqvist L, Permert J.

    Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R605-11.PMID: 11171636 [PubMed - indexed for MEDLINE]Related articles

    9.

    Ghrelin stimulates gastric emptying and hunger in normal-weight humans.

    Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, Degerblad M, Höybye C, Holst JJ, Rehfeld JF, Hellström PM, Näslund E.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3296-302. Epub 2006 Jun 13.PMID: 16772353 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats.

    Chen CY, Chao Y, Chang FY, Chien EJ, Lee SD, Doong ML.

    Int J Mol Med. 2005 Oct;16(4):695-9.PMID: 16142407 [PubMed - indexed for MEDLINE]Related articles

    11.

    Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.

    Riediger T, Bothe C, Becskei C, Lutz TA.

    Neuroendocrinology. 2004;79(6):317-26. Epub 2004 Jul 15.PMID: 15256809 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat.

    Levin F, Edholm T, Ehrström M, Wallin B, Schmidt PT, Kirchgessner AM, Hilsted LM, Hellström PM, Näslund E.

    Regul Pept. 2005 Nov;131(1-3):59-65.PMID: 16040140 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats.

    Reidelberger RD, Kelsey L, Heimann D.

    Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1395-404.PMID: 11959682 [PubMed - indexed for MEDLINE]Related articles

    14.

    Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

    Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ.

    Scand J Gastroenterol. 1994 Jun;29(6):501-5.PMID: 7915853 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.

    Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C.

    J Clin Endocrinol Metab. 2006 May;91(5):1916-23. Epub 2006 Feb 21.PMID: 16492694 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety.

    Schmidt PT, Näslund E, Grybäck P, Jacobsson H, Hartmann B, Holst JJ, Hellström PM.

    Regul Pept. 2003 Nov 15;116(1-3):21-5.PMID: 14599711 [PubMed - indexed for MEDLINE]Related articles

    17.

    Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

    Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM.

    Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11.PMID: 10193877 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dose-dependent effects of peptide YY(3-36) on conditioned taste aversion in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Peptides. 2006 Dec;27(12):3193-201. Epub 2006 Sep 7.PMID: 16962209 [PubMed - indexed for MEDLINE]Related articles

    19.

    Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.

    Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM.

    Surgery. 2005 Aug;138(2):283-90.PMID: 16153438 [PubMed - indexed for MEDLINE]Related articles

    20.

    Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.

    Ellrichmann M, Kapelle M, Ritter PR, Holst JJ, Herzig KH, Schmidt WE, Schmitz F, Meier JJ.

    J Clin Endocrinol Metab. 2008 Oct;93(10):3995-8. Epub 2008 Jul 22.PMID: 18647814 [PubMed - indexed for MEDLINE]Related articlesFree article